Clinical Trials Directory

Trials / Conditions / Effects of Immunotherapy

Effects of Immunotherapy

21 registered clinical trials studyying Effects of Immunotherapy — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingImpact of Gonadotoxic Therapies on Fertility
NCT05885048
Michael von Wolff—
RecruitingA Study of TIL in Advanced Solid Tumors (DFGD)
NCT06488950
Shanghai Juncell TherapeuticsEARLY_Phase 1
CompletedA Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital)
NCT05468307
Shanghai Juncell TherapeuticsEARLY_Phase 1
RecruitingA Clinical Study on TIL for the Treatment of Advanced Solid Tumors
NCT05087745
Shanghai Juncell TherapeuticsEARLY_Phase 1
RecruitingA Study of GC101 TIL in Advanced Breast Cancer (10hospital)
NCT05142475
Shanghai Juncell TherapeuticsEARLY_Phase 1
UnknownReal-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC
NCT05420922
Tongji Hospital—
RecruitingA Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
NCT05098197
Shanghai Juncell TherapeuticsEARLY_Phase 1
RecruitingA Study of GC101 TIL in Advanced Melanoma (10hospital)
NCT05098184
Shanghai Juncell TherapeuticsEARLY_Phase 1
RecruitingA Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
NCT05098171
Shanghai Juncell TherapeuticsEARLY_Phase 1
CompletedSerum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunother
NCT04813380
Zagazig UniversityPhase 3
UnknownTIL and Anti-PD1 in Metastatic Melanoma
NCT03638375
Leiden UniversityPhase 1 / Phase 2
CompletedEffect of Sublingual Immunotherapy in Patients With Atopic Dermatitis
NCT03388866
Casa Espirita Terra de IsmaelPhase 4
CompletedAnti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma
NCT02765243
Zhujiang HospitalPhase 1
CompletedAxalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
NCT02164461
Advaxis, Inc.Phase 1
CompletedTrial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma
NCT02406183
RadiotherapiePhase 1
CompletedSafety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma
NCT02169609
Fundació Sant Joan de DéuPhase 2
CompletedSafety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma
NCT01863108
University Hospital, GrenoblePhase 1
UnknownSafety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion
NCT01513109
Jules Bordet InstitutePhase 1 / Phase 2
CompletedDistinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunot
NCT01291381
Beijing Tongren HospitalN/A
CompletedQuality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy
NCT01486498
Aalborg University—
WithdrawnSCH708980 With and Without AmBisome for Visceral Leishmaniasis
NCT01437020
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1 / Phase 2